Stay updated with breaking news from Ruby Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Christian Marth, MD, PhD, and Bradley J. Monk, MD, FACS, FACOG, discuss data from the NRG GY018 and RUBY trials regarding the use of immunotherapies for the treatment of endometrial cancer.
A clinical trial that's attempting to discover a cure for sickle cell disease has found a new gene therapy to be safe and successful in four patients.
People diagnosed with sickle cell disease can now rejoice, as a recent study has discovered a potential cure for the painful disease. Researchers have discovered that a novel gene therapy has...
Researchers have revealed positive preliminary data from a CRISPR gene therapy trial for sickle cell disease.
The European Medicines Agency has validated a type II variation for potential approval of dostarlimab in combination with carboplatin and paclitaxel for the treatment of patients with mismatch repair–deficient/microsatellite instability–high primary advanced or recurrent endometrial cancer.